With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this latin america breast biopsy needle market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. Every possible effort has been taken while researching and analysing information to prepare this latin america breast biopsy needle market research report. This market research report contains thorough analysis of the market structure along with forecast of the various segments and sub-segments of the market.
 
Latin America Breast Biopsy Needle Market is expected to reach USD 32.25 million by 2028 from USD 17.97 million in 2020, growing at a steady CAGR of 7.7% in the forecast period of 2021 to 2028.
 
Download Sample PDF Copy of this Report to understand structure of the complete report (Including Full TOC, Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=latin-america-breast-biopsy-needle-market
 
Market Overview:
 
A Breast biopsy needle is a breast biopsy test that uses a needle to remove tissue or fluid from the suspicious area. These removed cells are further examined under a microscope and tested to check for breast cancer. It helps to determine if the suspicious area is cancerous. Several breast biopsy procedures are used to obtain a tissue sample from the breast. The doctor may recommend a particular procedure based on the size, location, and other characteristics of the breast abnormality. However, the two most used needles for breast biopsy is fine-needle aspiration and core needle.
 
Some of the major players operating in the breast biopsy needle market are Medax SRL , Cook, BD, AprioMed AB, INRAD Inc., Hologic, Inc., Möller Medical GmbH, IZI Medical Products, Merit Medical Systems, Inc., ADRIA MEDICAL, Devicor Medical Products Inc., Remington Medical Inc, PAJUNK and among others.
 
Latin America Breast Biopsy Needle Market Scope and Market Size:
 
Latin America breast biopsy needle market is segmented into seven notable segments based on needle type, ergonomics, procedure, usability, application, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
 
  • On the basis of needle type, the breast biopsy needle market is segmented into fine-needle aspiration, core needle. In 2021, core needle segment is expected to dominate the market due to the wide acceptance as it is capable of high accuracy treatment of breast lesions in short time.
  • On the basis of ergonomics, the breast biopsy needle market is segmented into sharp, blunt, quincke, chiba, franseen and others. In   2021, sharp segment is expected to dominate breast biopsy needle market as it is majorly preferred by doctors in examining breast lesions.
  • Brazil is dominating the Latin America breast biopsy needle market due to growing number of breast cancers in the region.
  • On the basis of procedure, the breast biopsy needle market is segmented into fine- needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. The image-guided biopsy is further segmented into ultrasound-guided core needle biopsy and mri-guided core needle biopsy. In 2021, image-guided biopsy segment is expected to dominate the market due to greater acceptance and ease in doing the breast biopsy procedure.
  • On the basis of usability, the breast biopsy needle market is segmented disposable and reusable. In 2021, disposable segment is expected to dominate the market because it is cheaper
  • On the basis of application, the breast biopsy needle market is segmented into early cancer screening, therapy selection, treatment monitoring and recurrence monitoring. In 2021, early cancer screening segment is expected to dominate the market due to the rise in cases of breast cancer worldwide.
  • On the basis of end user, the breast biopsy needle market is segmented into hospitals, diagnostic centers, biopsy labs, ambulatory surgical centers, academic and research organizations and others. In 2021, hospital segment is expected to dominate the market due to the rise in number of cancer patients treated in the hospitals.
  • On the basis of distribution channel, the breast biopsy needle market is segmented into direct tender and retail sales. In 2021, the direct tender segment is expected to dominate the market as it is an easy and convenient option to buy the product.
 
 
TABLE OF CONTENTS
 
Part 01: Executive Summary
 
Part 02: Scope of the Report
 
Part 03: Research Methodology
 
Part 04: Market Landscape
 
Part 05: Pipeline Analysis
 
Part 06: Market Sizing
 
Part 07: Five Forces Analysis
 
Part 08: Market Segmentation
 
Part 09: Customer Landscape
 
Part 10: Regional Landscape
 
Part 11: Decision Framework
 
Part 12: Drivers and Challenges
 
Part 13: Market Trends
 
Part 14: Vendor Landscape
 
Part 15: Vendor Analysis
 
Part 16: Appendix
 
Check Complete Table of Contents with List of Table and Figures @ https://www.databridgemarketresearch.com/toc/?dbmr=latin-america-breast-biopsy-needle-market
 
Browse Trending Reports:
 
 
 
About Data Bridge Market Research:
 
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
 
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
 
Contact Us: -
 
Data Bridge Market Research
 
US: +1 888 387 2818
 
United Kingdom: +44 208 089 1725
 
Hong Kong: +852 8192 7475